Share Twitter LinkedIn Facebook Email Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center evaluates the complexities of managing advanced/refractory metastatic colorectal cancer (mCRC).
Pashtoon Kasi MD, MS – The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management – ASCO GI 2025 Colorectal 4 Mins Read
FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival Colorectal 3 Mins Read
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read